Your browser doesn't support javascript.
loading
Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401.
Chung, David J; Shah, Nina; Wu, Juan; Logan, Brent; Bisharat, Lina; Callander, Natalie; Cheloni, Giulia; Anderson, Kenneth; Chodon, Thinle; Dhakal, Binod; Devine, Steve; Somaiya Dutt, Poorvi; Efebera, Yvonne; Geller, Nancy; Ghiasuddin, Haider; Hematti, Peiman; Holmberg, Leona; Howard, Alan; Johnson, Bryon; Karagkouni, Dimitra; Lazarus, Hillard M; Malek, Ehsan; McCarthy, Philip; McKenna, David; Mendizabal, Adam; Nooka, Ajay; Munshi, Nikhil; O'Donnell, Lynn; Rapoport, Aaron P; Reese, Jane; Rosenblatt, Jacalyn; Soiffer, Robert; Stroopinsky, Dina; Uhl, Lynne; Vlachos, Ioannis S; Waller, Edmund K; Young, James W; Pasquini, Marcelo C; Avigan, David.
Afiliación
  • Chung DJ; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Shah N; University of California San Francisco, San Francisco, California.
  • Wu J; Emmes Company, Rockville, Maryland.
  • Logan B; Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Bisharat L; Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Callander N; University of Wisconsin, Madison, Wisconsin.
  • Cheloni G; Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Anderson K; Dana Farber Cancer Institute, Boston, Massachusetts.
  • Chodon T; Roswell Park Cancer Institute, Buffalo, New York.
  • Dhakal B; Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Devine S; National Marrow Donor Program, Minneapolis, Minnesota.
  • Somaiya Dutt P; Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Efebera Y; OhioHealth, Columbus, Ohio.
  • Geller N; National Lung, Heart and Blood Institute, Rockville, Maryland.
  • Ghiasuddin H; Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Hematti P; University of Wisconsin, Madison, Wisconsin.
  • Holmberg L; Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Howard A; Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Johnson B; Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Karagkouni D; Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Lazarus HM; Case Western Reserve University, Cleveland, Ohio.
  • Malek E; Case Western Reserve University, Cleveland, Ohio.
  • McCarthy P; Roswell Park Cancer Institute, Buffalo, New York.
  • McKenna D; University of Minnesota, Minneapolis, Minnesota.
  • Mendizabal A; Emmes Company, Rockville, Maryland.
  • Nooka A; Emory University, Atlanta, Georgia.
  • Munshi N; Dana Farber Cancer Institute, Boston, Massachusetts.
  • O'Donnell L; Ohio State University, Columbus, Ohio.
  • Rapoport AP; University of Maryland, Baltimore, Maryland.
  • Reese J; Case Western Reserve University, Cleveland, Ohio.
  • Rosenblatt J; Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Soiffer R; Dana Farber Cancer Institute, Boston, Massachusetts.
  • Stroopinsky D; Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Uhl L; Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Vlachos IS; Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Waller EK; Emory University, Atlanta, Georgia.
  • Young JW; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Pasquini MC; Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Avigan D; Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Clin Cancer Res ; 29(23): 4784-4796, 2023 12 01.
Article en En | MEDLINE | ID: mdl-37463058

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Mieloma Múltiple Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Mieloma Múltiple Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article